How to Buy Remus Pharmaceuticals Ltd Shares?
You can easily buy the stocks/shares of Remus Pharmaceuticals Ltd (REMUS) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Remus Pharmaceuticals Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of REMUS as on 15th May 2025 is ₹2160.54What is the return on Remus Pharmaceuticals Ltd share?
The past returns of Remus Pharmaceuticals Ltd (REMUS) share are- Past 1 week: N/A
- Past 1 month: N/A
- Past 3 months: -9.00
- Past 6 months: -22.74
- Past 1 year: -4.89
- Past 3 years: N/A
- Past 5 years: 3.61
What is the Dividend yield % on Remus Pharmaceuticals Ltd share?
The current dividend yield of Remus Pharmaceuticals Ltd (REMUS) is N/AWhat is the Market Cap of Remus Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd (REMUS) is ₹1091.99Cr as of 15th May 2025What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?
The 52-week high and low of Remus Pharmaceuticals Ltd (REMUS) is ₹2834.75 and ₹1785.10.What is the PE and PB ratio of Remus Pharmaceuticals Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Remus Pharmaceuticals Ltd are 37.56 and 10.47 respectively.Which sector does Remus Pharmaceuticals Ltd belong to?
Remus Pharmaceuticals Ltd (REMUS) belongs to the Health Care sector & Pharmaceuticals sub-sector.What are the peers or stocks similar to Remus Pharmaceuticals Ltd?
The peers or stocks similar to Remus Pharmaceuticals Ltd are: and many others.Can't decide whether or not to buy Remus Pharmaceuticals Ltd?
Worry no more! Login to Tickertape and check out Remus Pharmaceuticals Ltd (REMUS) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?
The 52-week high and low of Remus Pharmaceuticals Ltd (REMUS) is ₹2834.75 and ₹1785.10.1. Test Stocks FAQ for Remus Pharmaceuticals Ltd Shares?
You can easily buy the stocks/shares of Remus Pharmaceuticals Ltd (REMUS) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Remus Pharmaceuticals Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of REMUS as on 15th May 2025 is ₹2160.54
Remus Pharmaceuticals Ltd
REMUS Share Price
2,160.540.30% (+6.54)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
REMUS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
REMUS Performance & Key Metrics
REMUS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 10.47 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.65 | 6.55 | 0.83% |
REMUS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
REMUS Company Profile
Remus Pharmaceuticals Ltd markets and distributes pharmaceutical formulations and active pharmaceutical ingredients, specializing in various therapeutic areas including oncology and cardiovascular health.
SUNPHARMA
PE Ratio
36.18
36.18
1Y Return
13.20%
13.20%
Buy Reco %
89.19
89.19
CIPLA
PE Ratio
22.95
22.95
1Y Return
2.92%
2.92%
Buy Reco %
71.05
71.05
DRREDDY
PE Ratio
19.32
19.32
1Y Return
10.98%
10.98%
Buy Reco %
82.05
82.05
TORNTPHARM
PE Ratio
57.15
57.15
1Y Return
10.81%
10.81%
Buy Reco %
67.74
67.74
MANKIND
PE Ratio
48.88
48.88
1Y Return
4.22%
4.22%
Buy Reco %
—
—
REMUS Sentiment Analysis
REMUS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
REMUS Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
REMUS Stock Growth Drivers
REMUS Stock Growth Drivers
4Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
REMUS Stock Challenges
REMUS Stock Challenges
3Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
REMUS Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
REMUS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
REMUS
REMUS
Income
Balance Sheet
Cash Flow
Annual Normal View
REMUS Income Statement
REMUS Income Statement
Annual Normal View
| Financial Year | FY 2024 | FY 2025 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 217.90 | 625.34 | — | |||
Raw Materials | 164.99 | 574.67 | — | |||
| Power & Fuel Cost | 0.00 | |||||
| Employee Cost | 7.42 | |||||
| Selling & Administrative Expenses | 5.25 | |||||
| Operating & Other expenses | 7.02 | |||||
EBITDA | 33.22 | 50.67 | — | |||
| Depreciation/Amortization | 0.90 | 1.87 | — | |||
| PBIT | 32.32 | 48.80 | — | |||
| Interest & Other Items | 0.48 | 1.46 | — | |||
| PBT | 31.84 | 47.34 | — | |||
| Taxes & Other Items | 10.30 | 18.27 | — | |||
| Net Income | 21.54 | 29.07 | — | |||
| EPS | 36.56 | 65.21 | — | |||
| DPS | 0.00 | 0.00 | — | |||
| Payout ratio | 0.00 | 0.00 | — |
REMUS Company Updates
REMUS Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
REMUS Past Performance & Peer Comparison
REMUS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Remus Pharmaceuticals Ltd | 37.56 | 10.47 | — |
| Sun Pharmaceutical Industries Ltd | 36.18 | 5.89 | 0.97% |
| Cipla Ltd | 22.95 | 4.51 | 1.07% |
| Dr Reddy's Laboratories Ltd | 19.32 | 3.87 | 0.61% |
REMUS Stock Price Comparison
Compare REMUS with any stock or ETFCompare REMUS with any stock or ETF
REMUS
REMUS Holdings
REMUS Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
REMUS Promoter Holdings Trend
REMUS Promoter Holdings Trend
REMUS Institutional Holdings Trend
REMUS Institutional Holdings Trend
No institutional holdings trend are available
REMUS Shareholding Pattern
REMUS Shareholding Pattern
REMUS Shareholding History
REMUS Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing REMUS stock
smallcases containing REMUS stock
Looks like this stock is not in any smallcase yet.
REMUS Events
REMUS Events
REMUS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
REMUS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
REMUS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
REMUS has not given any dividends in last 5 years
REMUS Upcoming Dividends
REMUS Upcoming Dividends
No upcoming dividends are available
REMUS Past Dividends
REMUS Past Dividends
Cash Dividend
Ex DateEx DateNov 19, 2024
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 19, 2024
Cash Dividend
Ex DateEx DateOct 26, 2023
Interim
Interim | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Oct 26, 2023
Cash Dividend
Ex DateEx DateSep 14, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 14, 2023
REMUS Stock News & Opinions
REMUS Stock News & Opinions
Articles & Videos
Corporate
Board of Remus Pharmaceuticals recommends final dividend
Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 17 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Remus Pharmaceuticals recommends interim dividend
Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9 November 2024, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Remus Pharmaceuticals to convene board meeting
Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Remus Pharmaceuticals to convene AGM
Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant